Cargando…

Osteogenic and Adipogenic Differentiation Potential of Oral Cancer Stem Cells May Offer New Treatment Modalities

(1) Treatment failure of oral squamous cell carcinoma (OSCC) is generally due to the development of therapeutic resistance caused by the existence of cancer stem cells (CSCs), a small cell subpopulation with marked self-renewal and differentiation capacity. Micro RNAs, notably miRNA-21, appear to pl...

Descripción completa

Detalles Bibliográficos
Autores principales: Jaksic Karisik, Milica, Lazarevic, Milos, Mitic, Dijana, Nikolic, Nadja, Milosevic Markovic, Maja, Jelovac, Drago, Milasin, Jelena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10002556/
https://www.ncbi.nlm.nih.gov/pubmed/36902135
http://dx.doi.org/10.3390/ijms24054704
_version_ 1784904417049313280
author Jaksic Karisik, Milica
Lazarevic, Milos
Mitic, Dijana
Nikolic, Nadja
Milosevic Markovic, Maja
Jelovac, Drago
Milasin, Jelena
author_facet Jaksic Karisik, Milica
Lazarevic, Milos
Mitic, Dijana
Nikolic, Nadja
Milosevic Markovic, Maja
Jelovac, Drago
Milasin, Jelena
author_sort Jaksic Karisik, Milica
collection PubMed
description (1) Treatment failure of oral squamous cell carcinoma (OSCC) is generally due to the development of therapeutic resistance caused by the existence of cancer stem cells (CSCs), a small cell subpopulation with marked self-renewal and differentiation capacity. Micro RNAs, notably miRNA-21, appear to play an important role in OSCC carcinogenesis. Our objectives were to explore the multipotency of oral CSCs by estimating their differentiation capacity and assessing the effects of differentiation on stemness, apoptosis, and several miRNAs’ expression. (2) A commercially available OSCC cell line (SCC25) and five primary OSCC cultures generated from tumor tissues obtained from five OSCC patients were used in the experiments. Cells harboring CD44, a CSC marker, were magnetically separated from the heterogeneous tumor cell populations. The CD44(+) cells were then subjected to osteogenic and adipogenic induction, and the specific staining was used for differentiation confirmation. The kinetics of the differentiation process was evaluated by qPCR analysis of osteogenic (Bone Morphogenetic Protein—BMP4, Runt-related Transcription Factor 2—RUNX2, Alkaline Phosphatase—ALP) and adipogenic (Fibroblast Activation Protein Alpha—FAP, LIPIN, Peroxisome Proliferator-activated Receptor Gamma—PPARG) markers on days 0, 7, 14, and 21. Embryonic markers (Octamer-binding Transcription Factor 4—OCT4, Sex Determining Region Y Box 2—SOX2, and NANOG) and micro RNAs (miRNA-21, miRNA-133, and miRNA-491) were also correspondingly evaluated by qPCR. An Annexin V assay was used to assess the potential cytotoxic effects of the differentiation process. (3) Following differentiation, the levels of markers for the osteo/adipo lineages showed a gradual increase from day 0 to day 21 in the CD44(+) cultures, while stemness markers and cell viability decreased. The oncogenic miRNA-21 also followed the same pattern of gradual decrease along the differentiation process, while tumor suppressor miRNA-133 and miRNA-491 levels increased. (4) Following induction, the CSCs acquired the characteristics of the differentiated cells. This was accompanied by loss of stemness properties, a decrease of the oncogenic and concomitant, and an increase of tumor suppressor micro RNAs.
format Online
Article
Text
id pubmed-10002556
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-100025562023-03-11 Osteogenic and Adipogenic Differentiation Potential of Oral Cancer Stem Cells May Offer New Treatment Modalities Jaksic Karisik, Milica Lazarevic, Milos Mitic, Dijana Nikolic, Nadja Milosevic Markovic, Maja Jelovac, Drago Milasin, Jelena Int J Mol Sci Article (1) Treatment failure of oral squamous cell carcinoma (OSCC) is generally due to the development of therapeutic resistance caused by the existence of cancer stem cells (CSCs), a small cell subpopulation with marked self-renewal and differentiation capacity. Micro RNAs, notably miRNA-21, appear to play an important role in OSCC carcinogenesis. Our objectives were to explore the multipotency of oral CSCs by estimating their differentiation capacity and assessing the effects of differentiation on stemness, apoptosis, and several miRNAs’ expression. (2) A commercially available OSCC cell line (SCC25) and five primary OSCC cultures generated from tumor tissues obtained from five OSCC patients were used in the experiments. Cells harboring CD44, a CSC marker, were magnetically separated from the heterogeneous tumor cell populations. The CD44(+) cells were then subjected to osteogenic and adipogenic induction, and the specific staining was used for differentiation confirmation. The kinetics of the differentiation process was evaluated by qPCR analysis of osteogenic (Bone Morphogenetic Protein—BMP4, Runt-related Transcription Factor 2—RUNX2, Alkaline Phosphatase—ALP) and adipogenic (Fibroblast Activation Protein Alpha—FAP, LIPIN, Peroxisome Proliferator-activated Receptor Gamma—PPARG) markers on days 0, 7, 14, and 21. Embryonic markers (Octamer-binding Transcription Factor 4—OCT4, Sex Determining Region Y Box 2—SOX2, and NANOG) and micro RNAs (miRNA-21, miRNA-133, and miRNA-491) were also correspondingly evaluated by qPCR. An Annexin V assay was used to assess the potential cytotoxic effects of the differentiation process. (3) Following differentiation, the levels of markers for the osteo/adipo lineages showed a gradual increase from day 0 to day 21 in the CD44(+) cultures, while stemness markers and cell viability decreased. The oncogenic miRNA-21 also followed the same pattern of gradual decrease along the differentiation process, while tumor suppressor miRNA-133 and miRNA-491 levels increased. (4) Following induction, the CSCs acquired the characteristics of the differentiated cells. This was accompanied by loss of stemness properties, a decrease of the oncogenic and concomitant, and an increase of tumor suppressor micro RNAs. MDPI 2023-02-28 /pmc/articles/PMC10002556/ /pubmed/36902135 http://dx.doi.org/10.3390/ijms24054704 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Jaksic Karisik, Milica
Lazarevic, Milos
Mitic, Dijana
Nikolic, Nadja
Milosevic Markovic, Maja
Jelovac, Drago
Milasin, Jelena
Osteogenic and Adipogenic Differentiation Potential of Oral Cancer Stem Cells May Offer New Treatment Modalities
title Osteogenic and Adipogenic Differentiation Potential of Oral Cancer Stem Cells May Offer New Treatment Modalities
title_full Osteogenic and Adipogenic Differentiation Potential of Oral Cancer Stem Cells May Offer New Treatment Modalities
title_fullStr Osteogenic and Adipogenic Differentiation Potential of Oral Cancer Stem Cells May Offer New Treatment Modalities
title_full_unstemmed Osteogenic and Adipogenic Differentiation Potential of Oral Cancer Stem Cells May Offer New Treatment Modalities
title_short Osteogenic and Adipogenic Differentiation Potential of Oral Cancer Stem Cells May Offer New Treatment Modalities
title_sort osteogenic and adipogenic differentiation potential of oral cancer stem cells may offer new treatment modalities
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10002556/
https://www.ncbi.nlm.nih.gov/pubmed/36902135
http://dx.doi.org/10.3390/ijms24054704
work_keys_str_mv AT jaksickarisikmilica osteogenicandadipogenicdifferentiationpotentialoforalcancerstemcellsmayoffernewtreatmentmodalities
AT lazarevicmilos osteogenicandadipogenicdifferentiationpotentialoforalcancerstemcellsmayoffernewtreatmentmodalities
AT miticdijana osteogenicandadipogenicdifferentiationpotentialoforalcancerstemcellsmayoffernewtreatmentmodalities
AT nikolicnadja osteogenicandadipogenicdifferentiationpotentialoforalcancerstemcellsmayoffernewtreatmentmodalities
AT milosevicmarkovicmaja osteogenicandadipogenicdifferentiationpotentialoforalcancerstemcellsmayoffernewtreatmentmodalities
AT jelovacdrago osteogenicandadipogenicdifferentiationpotentialoforalcancerstemcellsmayoffernewtreatmentmodalities
AT milasinjelena osteogenicandadipogenicdifferentiationpotentialoforalcancerstemcellsmayoffernewtreatmentmodalities